Tsukita Yoko

Affiliation and department：
Homepage URL (1)： http://www.rm.med.tohoku.ac.jp/

Research field (1)： Respiratory medicine

Research keywords (3)：胸部腫瘍学 , 臨床試験 , 肺癌

Research theme for competitive and other funds (2)：

2020 - 2023 免疫抵抗性克服のための非小細胞肺癌における放射線照射がもたらす免疫応答の解析
2019 - 2020 The role of reactive sulfur species and cysteinyl-tRNA synthetase2 in lung cancer

Papers (63)：

Hayato Kawachi, Motohiro Tamiya, Yuko Oya, Go Saito, Yoshihiko Taniguchi, Hirotaka Matsumoto, Yuki Sato, Taiichiro Otsuki, Hidekazu Suzuki, Yasushi Fukuda, et al. Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005). Clinical lung cancer. 2024. 25. 7. 643-652
Ryota Shibaki, Daichi Fujimoto, Eisaku Miyauchi, Yoko Tsukita, Ichiro Nakachi, Daisuke Arai, Yoshihiko Sakata, Naoki Shingu, Toshio Shimokawa, Takashi Kijima, et al. Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial. Lung cancer (Amsterdam, Netherlands). 2024. 196. 107958-107958
Tetsuhiko Asao, Takehito Shukuya, Kohei Uemura, Rui Kitadai, Gaku Yamamoto, Atsuto Mouri, Meiyo Tamaoka, Ryosuke Imai, Yoko Tsukita, Kazutoshi Isobe, et al. Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047). Lung cancer (Amsterdam, Netherlands). 2024. 194. 107894-107894
岩崎史, 宮内栄作, 井上千裕, 青山弥生, 小泉照樹, 渋谷里紗, 突田容子, 木村望, 伊藤辰徳, 小野祥直, et al. 当院における進行期非小細胞肺癌患者に対する院内AMOY遺伝子変異検査の検査成功率とTurn Around Timeの検討. 気管支学. 2024. 46. Suppl. S292-S292
Nozomu Kimura, Yoko Tsukita, Risa Ebina-Shibuya, Eisaku Miyauchi, Mitsuhiro Yamada, Daisuke Narita, Ryota Saito, Chihiro Inoue, Naoya Fujino, Tomohiro Ichikawa, et al. Peripheral blood biomarkers associated with combination of immune checkpoint blockade plus chemotherapy in NSCLC. Cancer biomarkers : section A of Disease markers. 2024

ｍore...

MISC (41)：

渡辺匠, 平本航大, 沼倉忠久, 滝田克也, 宮内栄作, 突田容子, 杉浦久敏, 松本洋太郎, 富岡佳久. 修飾核酸一斉定量系を用いたCOPD早期発見手法の開発検討. 日本薬学会東北支部大会講演要旨集. 2020. 59th
宮内栄作, 松田達雄, 清谷一馬, LOW Siew-kee, 突田容子, 一ノ瀬正和, 桜田晃, 岡田克典, 齊藤涼子, 中村祐輔. TCR repertoires in lung adenocarcinomas with and without EGFR mutation. 日本癌学会学術総会抄録集(Web). 2019. 78th
宮内栄作, 成田大輔, 相澤洋之, 村上康司, 小林誠, 突田容子, 東出直樹, 齋藤良太, 佐藤輝幸, 杉浦久敏, et al. 胸腔鏡下肺切除術で診断された印環細胞癌様の形態を呈した肺腺癌の1例. 肺癌(Web). 2019. 59. 5
Eisaku Miyauchi, Tatsuo Matsuda, Yu-wen Hsu, Yoko Tsukita, Masakazu Ichinose, Akira Sakurada, Yoshinori Okada, Ryoko Saito, Kazuma Kiyotani, Yusuke Nakamura. T cell receptor repertoire analysis of lung adenocarcinoma harboring EGFR mutations. CANCER SCIENCE. 2018. 109. 1178-1178
突田容子, 宮内栄作, 齊藤涼子, 岡崎達馬, 井上彰, 岡田克典, 一ノ瀬正和. EGFR遺伝子変異陽性肺腺癌においてAXLキナーゼは免疫抑制分子を促進する(Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas). 日本癌学会総会記事. 2018. 77回. 1885-1885

ｍore...

Education (2)：

2014 - 2018 Tohoku University Graduate School of Medicine
2003 - 2009 Yamagata University Faculty of Medicine School of Medicine

Professional career (1)：

博士

Work history (7)：

2020/05 - 現在東北大学呼吸器内科助教
2020/04 - 2020/05 東北大学呼吸器内科特任助手
2018/04 - 2020/03 東北大学呼吸器内科医員
2012/10 - 2015/03 宮城県立がんセンター呼吸器内科
2011/10 - 2012/09 東北厚生年金病院呼吸器内科レジデント

Show all

Awards (3)：

2020 - 日本肺癌学会若手奨励賞
2019 - 日本呼吸器学会 ATS Young Investigator
2019 - 東北大学医学系研究科女子大学院学生奨励賞(七星賞) 優秀賞

Association Membership(s) (7)：

THE JAPANESE CANCER ASSOCIATION , 米国臨床腫瘍学会 , THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY , 日本臨床腫瘍学会 , THE JAPAN LUNG CANCER SOCIETY , THE JAPANESE RESPIRATORY SOCIETY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page